Xenon Pharmaceuticals Inc. Q2 2024 Earnings Call Transcript
XENE Stock | USD 38.52 1.10 2.78% |
About 61% of Xenon Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Xenon |
Operator Thank you for standing by. My name is Meg, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2024 Xenon Pharmaceuticals, Inc.
Read at insidermonkey.com
Xenon Pharmaceuticals Fundamental Analysis
We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Xenon Pharmaceuticals is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Xenon Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Xenon Pharmaceuticals Related Equities
REPL | Replimune | 16.86 | ||||
VTYX | Ventyx Biosciences | 6.88 | ||||
ANAB | AnaptysBio | 6.50 | ||||
VRDN | Viridian Therapeutics | 6.27 | ||||
MGTX | MeiraGTx Holdings | 5.56 | ||||
IDYA | Ideaya Biosciences | 4.37 | ||||
CRNX | Crinetics Pharmaceuticals | 3.78 | ||||
PCVX | Vaxcyte | 3.36 | ||||
KROS | Keros Therapeutics | 3.23 | ||||
UTHR | United Therapeutics | 2.52 | ||||
ASND | Ascendis Pharma | 2.29 | ||||
MRUS | Merus BV | 0.74 | ||||
CYTK | Cytokinetics | 0.17 | ||||
ACLX | Arcellx | 0.14 | ||||
NUVL | Nuvalent | 0.20 | ||||
INBX | Inhibrx | 0.37 | ||||
LYEL | Lyell Immunopharma | 1.72 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
KRON | Kronos Bio | 1.98 | ||||
DYN | Dyne Therapeutics | 4.33 |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |